Search

Your search keyword '"Vommaro RC"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Vommaro RC" Remove constraint Author: "Vommaro RC"
49 results on '"Vommaro RC"'

Search Results

1. Inflammatory response and parasite regulation in acute toxoplasmosis: the role of P2X7 receptor in controlling virulent atypical genotype strain of Toxoplasma gondii .

2. Potent hydroxamate-derived compounds arrest endodyogeny of Toxoplasma gondii tachyzoites.

3. An alternative method to establish an early acute ocular toxoplasmosis model for experimental tests.

4. P2X7 Receptor Modulation of the Gut Microbiota and the Inflammasome Determines the Severity of Toxoplasma gondii -Induced Ileitis.

5. Binding of the extracellular matrix laminin-1 to Clostridioides difficile strains.

6. Characterization of an emergent high-risk KPC-producing Klebsiella pneumoniae lineage causing a fatal wound infection after spine surgery.

7. HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics.

8. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.

9. The life-cycle of Toxoplasma gondii reviewed using animations.

10. Disruption of Purinergic Receptor P2X7 Signaling Increases Susceptibility to Cerebral Toxoplasmosis.

11. Toxoplasma gondii reorganizes the host cell architecture during spontaneous cyst formation in vitro.

12. Identification of the alpha-enolase P46 in the extracellular membrane vesicles of Bacteroides fragilis.

13. The P2X7 Receptor Mediates Toxoplasma gondii Control in Macrophages through Canonical NLRP3 Inflammasome Activation and Reactive Oxygen Species Production.

14. A Glycosylphosphatidylinositol-Anchored Carbonic Anhydrase-Related Protein of Toxoplasma gondii Is Important for Rhoptry Biogenesis and Virulence.

15. Inflammatory early events associated to the role of P2X7 receptor in acute murine toxoplasmosis.

16. Assay to Access Anthelmintic Activity of Small Molecule Drugs Using Caenohabidtis elegans as a Model.

17. Anthelmintic effect of herbicidal dinitroanilines on the nematode model Caenorhabditis elegans.

18. Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoite and bradyzoite development in vitro and in vivo.

19. Pyrimidinergic Receptor Activation Controls Toxoplasma gondii Infection in Macrophages.

20. Ciprofloxacin Derivatives Affect Parasite Cell Division and Increase the Survival of Mice Infected with Toxoplasma gondii.

21. Pyrimethamine-loaded lipid-core nanocapsules to improve drug efficacy for the treatment of toxoplasmosis.

22. Inactivation of a fibronectin-binding TonB-dependent protein increases adhesion properties of Bacteroides fragilis.

23. Caenorhabditis elegans as a model for the screening of anthelminthic compounds: ultrastructural study of the effects of albendazole.

24. Spontaneous cystogenesis in vitro of a Brazilian strain of Toxoplasma gondii.

25. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.

26. The organization of the wall filaments and characterization of the matrix structures of Toxoplasma gondii cyst form.

27. New details on the fine structure of the rhoptry of Toxoplasma gondii.

28. Evaluation of three novel azasterols against Toxoplasma gondii.

29. Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages.

30. Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model.

31. The fine structure of the Acanthamoeba polyphaga cyst wall.

32. Thiolactomycin analogues as potential anti-Toxoplasma gondii agents.

33. Bacteroides fragilis induce necrosis on mice peritoneal macrophages: In vitro and in vivo assays.

34. Toxoplasma gondii: further studies on the subpellicular network.

35. The redox potential interferes with the expression of laminin binding molecules in Bacteroides fragilis.

36. Itraconazole affects Toxoplasma gondii endodyogeny.

37. Freeze-fracture study of the dynamics of Toxoplasma gondii parasitophorous vacuole development.

38. Antiproliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro.

39. Intravacuolar network may act as a mechanical support for Toxoplasma gondii inside the parasitophorous vacuole.

40. Antiproliferative synergism of azasterols and antifolates against Toxoplasma gondii.

41. Bacteroides fragilis interferes with iNOS activity and leads to pore formation in macrophage surface.

42. Cultured embryonic retina systems as a model for the study of underlying mechanisms of Toxoplasma gondii infection.

43. Selective anti-Toxoplasma gondii activities of azasterols.

44. Bacteroides fragilis adherence to Caco-2 cells.

45. Surface charge and surface carbohydrates of Cyptobia salmositica virulent and avirulent forms and of C. bullocki (Kinetoplastida: Cryptobiidae).

46. Computer aided three-dimensional reconstruction of the free-living protozoan Bodo sp. (Kinetoplastida:Bodonidae).

47. Freeze-fracture study of Bodo sp. (Kinetoplastida: Bodonidae).

48. The cell surface charge of Bodo sp. (Kinetoplastida: Bodonidae).

49. Comparative study of the surface charge of some isolates of trypanosomatids of the genus Phytomonas.

Catalog

Books, media, physical & digital resources